Kato, Y., Hosomi, Y., Watanabe, K., Yomota, M., Kawai, S., Okuma, Y., . . . Okamura, T. (2019). Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors. J Thorac Dis.
Dyfyniad Arddull ChicagoKato, Yasuhiro, et al. "Impact of Clinical Features On the Efficacy of Osimertinib Therapy in Patients With T790M-positive Non-small Cell Lung Cancer and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors." J Thorac Dis 2019.
Dyfyniad MLAKato, Yasuhiro, et al. "Impact of Clinical Features On the Efficacy of Osimertinib Therapy in Patients With T790M-positive Non-small Cell Lung Cancer and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors." J Thorac Dis 2019.